| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 34, 715-718, Copyright © 1988 by American Association for Clinical Chemistry
J Risteli, S Niemi, P Trivedi, O Maentausta, AP Mowat and L Risteli
Collagen Research Unit, Biocenter, Oulu, Finland.
This is an equilibrium-type radioimmunoassay for the amino-terminal propeptide of type III procollagen (PIIINP), which overcomes the problem of nonparallelism between the standard and human serum samples encountered with earlier assays. Proper selection of antiserum and reaction conditions diminishes interference from degradation products of the propeptide in serum. Because a rapid solid-phase-bound second- antibody step is included, the assay takes only 3 h. The intra-assay and the interassay CVs are both about 5%. In infants and children the concentration of PIIINP in serum closely parallels the growth-velocity curve. For 88 presumably healthy adults, the PIIINP concentration was 1.7-4.2 micrograms/L, about a third that measured with the previously available commercial assay. This is because of lack of inhibition by small Col 1 domain-related degradation products.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  B Mazieres, P Garnero, A Gueguen, M Abbal, L Berdah, M Lequesne, M Nguyen, J-P Salles, E Vignon, and M Dougados Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort Ann Rheum Dis, March 1, 2006; 65(3): 354 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rej Clinical Chemistry through Clinical Chemistry: A Journal Timeline Clin. Chem., December 1, 2004; 50(12): 2415 - 2458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Parkinson, M. Kassem, L. Heickendorff, A. Flyvbjerg, and P. J. Trainer Pegvisomant-Induced Serum Insulin-Like Growth Factor-I Normalization in Patients with Acromegaly Returns Elevated Markers of Bone Turnover to Normal J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5650 - 5655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Velling, J. Risteli, K. Wennerberg, D. F. Mosher, and S. Johansson Polymerization of Type I and III Collagens Is Dependent On Fibronectin and Enhanced By Integrins alpha 11beta 1 and alpha 2beta 1 J. Biol. Chem., September 27, 2002; 277(40): 37377 - 37381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Horstrup, M. Gehrmann, B. Schneider, A. Ploger, P. Froese, T. Schirop, D. Kampf, U. Frei, R. Neumann, and K.-U. Eckardt Elevation of serum and urine levels of TIMP-1 and tenascin in patients with renal disease Nephrol. Dial. Transplant., June 1, 2002; 17(6): 1005 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. Gravholt, A. L. Lauridsen, K. Brixen, L. Mosekilde, L. Heickendorff, and J. S. Christiansen Marked Disproportionality in Bone Size and Mineral, and Distinct Abnormalities in Bone Markers and Calcitropic Hormones in Adult Turner Syndrome: A Cross-Sectional Study J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2798 - 2808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Laitakari and F. Stenback Collagen Matrix in Development and Progression of Experimentally Induced Respiratory Neoplasms in the Hamster Toxicol Pathol, August 1, 2001; 29(5): 514 - 527. [Abstract] [PDF]
|
|
|
|
|
|
M. Iwahashi, Y. Muragaki, A. Ooshima, and R. Nakano Overexpression of Type IV Collagen in Chorionic Villi in Hydatidiform Mole J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2649 - 2652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Garnero, M Piperno, E Gineyts, S Christgau, P D Delmas, and E Vignon Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage Ann Rheum Dis, June 1, 2001; 60(6): 619 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Heuck, L. Heickendorff, and O. D Wolthers A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide Arch. Dis. Child., October 1, 2000; 83(4): 334 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Hytinantti, E-M Rutanen, M Turpeinen, R Sorva, and S Andersson Markers of collagen metabolism and insulin-like growth factor binding protein-1 in term infants Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2000; 83(1): 17F - 20. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Santala, M. Simojoki, J. Risteli, L. Risteli, and A. Kauppila Type I and Type III Collagen Metabolites as Predictors of Clinical Outcome in Epithelial Ovarian Cancer Clin. Cancer Res., December 1, 1999; 5(12): 4091 - 4096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Åman, J Risteli, R Luukkainen, L Risteli, M Kauppi, P Nieminen, and M Hakala The value of synovial fluid analysis in the assessment of knee joint destruction in arthritis in a three year follow up study Ann Rheum Dis, September 1, 1999; 58(9): 559 - 562. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. K. Bode, M. Mosorin, J. Satta, L. Risteli, T. Juvonen, and J. Risteli Complete Processing of Type III Collagen in Atherosclerotic Plaques Arterioscler. Thromb. Vasc. Biol., June 1, 1999; 19(6): 1506 - 1511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Moller, M Hansen, J Hillingso, J-E B Jensen, and J H Henriksen Elevated carboxy terminal cross linked telopeptide of type I collagen in alcoholic cirrhosis: relation to liver and kidney function and bone metabolism Gut, March 1, 1999; 44(3): 417 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. LAMMI, L. RYHÄNEN, E. LAKARI, J. RISTELI, P. PÄÄKKÖ, K. KAHLOS, S. LÄHDE, and V. KINNULA Type III and Type I Procollagen Markers in Fibrosing Alveolitis Am. J. Respir. Crit. Care Med., March 1, 1999; 159(3): 818 - 823. [Abstract] [Full Text]
|
|
|
|
|
|
P. M. Crofton, S. F. Ahmed, J. C. Wade, R. Stephen, M. W. Elmlinger, M. B. Ranke, C. J. H. Kelnar, and W. H. B. Wallace Effects of Intensive Chemotherapy on Bone and Collagen Turnover and the Growth Hormone Axis in Children with Acute Lymphoblastic Leukemia J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3121 - 3129. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Uusimaa, J. Risteli, M. Niemela, J. Lumme, M. Ikaheimo, A. Jounela, and K. Peuhkurinen Collagen Scar Formation After Acute Myocardial Infarction : Relationships to Infarct Size, Left Ventricular Function, and Coronary Artery Patency Circulation, October 21, 1997; 96(8): 2565 - 2572. [Abstract] [Full Text]
|
|
|
|
|
|
G. Osella, M. Terzolo, G. Reimondo, A. Piovesan, A. Pia, A. Termine, P. Paccotti, and A. Angeli Serum Markers of Bone and Collagen Turnover in Patients with Cushing's Syndrome and in Subjects with Adrenal Incidentalomas J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3303 - 3307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Crofton, J. C. Wade, M. R. H. Taylor, and C. V. Holland Serum concentrations of carboxyl-terminal propeptide of type I procollagen, amino-terminal propeptide of type III procollagen, cross-linked carboxyl-terminal telopeptide of type I collagen, and their interrelationships in schoolchildren Clin. Chem., September 1, 1997; 43(9): 1577 - 1581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Diez, C. Laviades, G. Mayor, M. J. Gil, and I. Monreal Increased Serum Concentrations of Procollagen Peptides in Essential Hypertension : Relation to Cardiac Alterations Circulation, March 1, 1995; 91(5): 1450 - 1456. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
